David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLYA
1901
DELISTED
Playa Hotels & Resorts
PLYA
| $4.7M | ﹤0.01% |
371,399
-188,110
| -34% | -$1.78M |
|
1902
PUT
PennyMac Financial
PFSI
$3.79B
| $4.69M | ﹤0.01% |
45,900
+2,700
| +6% | +$282K |
|
1903
CALL
Magna International
MGA
$17.7B
| $4.68M | ﹤0.01% |
112,100
| – | – |
|
1904
PUT
Thermo Fisher Scientific
TMO
$234B
| $4.68M | ﹤0.01% |
+9,000
| New | +$4.95M |
|
1905
CALL
Aptiv
APTV
$9.61B
| $4.68M | ﹤0.01% |
77,300
+18,500
| +31% | +$1.13M |
|
|
BNY
1906
PUT
Bank of New York Mellon
BNY
$111B
| $4.67M | ﹤0.01% |
+60,800
| New | +$4.7M |
|
1907
Illumina
ILMN
$34B
| $4.67M | ﹤0.01% |
34,936
+1,800
| +5% | +$256K |
|
1908
Option Care Health
OPCH
$3.6B
| $4.66M | ﹤0.01% |
+200,751
| New | +$5.07M |
|
1909
Goldman Sachs
GS
$303B
| $4.66M | ﹤0.01% |
8,130
-44,069
| -84% | -$24.6M |
|
1910
PUT
Blue Owl Capital
OWL
$18.4B
| $4.65M | ﹤0.01% |
+200,000
| New | +$4.58M |
|
|
PCH
1911
DELISTED
PotlatchDeltic
PCH
| $4.65M | ﹤0.01% |
118,514
+35,664
| +43% | +$1.51M |
|
1912
IDEAYA Biosciences
IDYA
$4.01B
| $4.64M | ﹤0.01% |
180,676
-387,055
| -68% | -$11M |
|
|
BSII
1913
DELISTED
Black Spade Acquisition II Co Class A Ordinary Share
BSII
| $4.63M | ﹤0.01% |
+465,821
| New | +$4.61M |
|
1914
Xeris Biopharma Holdings
XERS
$1.58B
| $4.62M | ﹤0.01% |
1,363,452
+378,437
| +38% | +$1.22M |
|
1915
TETRA Technologies
TTI
$1.01B
| $4.62M | ﹤0.01% |
1,289,946
+403,086
| +45% | +$1.43M |
|
1916
STAG Industrial
STAG
$7.17B
| $4.61M | ﹤0.01% |
136,412
+123,129
| +927% | +$4.51M |
|
1917
CALL
GigaCloud Technology
GCT
$1.86B
| $4.61M | ﹤0.01% |
248,900
+179,200
| +257% | +$4.15M |
|
|
CVGW
1918
DELISTED
Calavo Growers
CVGW
| $4.6M | ﹤0.01% |
180,268
+57,575
| +47% | +$1.57M |
|
1919
PUT
Valaris
VAL
$5.8B
| $4.6M | ﹤0.01% |
103,900
+81,300
| +360% | +$3.91M |
|
1920
American Vanguard Corp
AVD
$65.2M
| $4.58M | ﹤0.01% |
990,238
+88,070
| +10% | +$477K |
|
1921
CALL
Alaska Air
ALK
$4.8B
| $4.58M | ﹤0.01% |
70,800
| – | – |
|
1922
Packaging Corp of America
PKG
$22B
| $4.58M | ﹤0.01% |
20,339
-6,352
| -24% | -$1.47M |
|
1923
Parker-Hannifin
PH
$131B
| $4.58M | ﹤0.01% |
7,199
-18,810
| -72% | -$12.5M |
|
1924
Laureate Education
LAUR
$5.33B
| $4.58M | ﹤0.01% |
250,336
+197,964
| +378% | +$3.47M |
|
1925
Essex Property Trust
ESS
$18.5B
| $4.58M | ﹤0.01% |
16,033
+10,510
| +190% | +$3.11M |
|
Similar funds
David Shaw's Q4 2024 Portfolio in Review
As of Q4 2024, David Shaw held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- David Shaw's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- David Shaw's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- David Shaw fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- David Shaw's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- David Shaw opened 591 new positions and closed 731 in Q4 2024.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.